VetTech
veterinary technologies corporation

home | español | principals | products | investment opportunities | contact 
  INVESTMENT OPPORTUNITIES

STANDARD RB51™ (For Brucellosis in cattle)

VetTech Marketing Agreements

SCHERING-PLOUGH
Schering-Plough markets the vaccine throughout Central and South America as well as exclusive distribution rights for sub-Sahara Africa including South Africa. Hertape, S.A., has manufacturing rights in Brazil.


PRONABIVE
PRONABIVE
of Mexico, a quasi-governmental private company, to produce and distribute in Mexico.

INDIAN IMMUNOLOGICAL LABORATORIES
Indian Immunological Laboratories and Vet Tech have a joint venture to manufacture and sell the vaccine in India.

CZV
CZU of Spain, to produce and market throughout Europe, the Middle East and Northwest Africa and Russia.


COLORADO SERUM
The present brucellosis vaccine is manufacturered by Colorado Serum in Denver, Colorado. VetTech in conjunction with Colorado Serum Co. is working with Malaysia and Indonesia to market the vaccine in those countries and has opened a dialogue with China on introducing the vaccine there.